Further research on the oncostatic action of a chemotherapeutic agent with anti-folic mechanism (trimethoprim-sulfamethoxazole)
La Pesa, M.; Curci, E.; Semeraro, N.; Mancini, L.
Pathologica 65(949): 391-392
1973
ISSN/ISBN: 0031-2983 PMID: 4597263 Document Number: 66017
Document emailed within 1 workday
Related Documents
Chanu, B.; Kernbaum, S.; Uzzan, B.; Faille, A.; Blasetti, A.; Rouffy, J. 1981: Bone marrow aplasia induced by sulfamethoxazole-trimethoprim. Evidence of an allergic mechanism La Nouvelle Presse Medicale 10(42): 3496-3497Feldman, W.; Johnson, D.M.; Newberry, P.; Weldon, A.; Naidoo, S. 1975: Comparison of trimethoprim-sulfamethoxazole with sulfamethoxazole in urinary tract infections of children Canadian Medical Association Journal 112(13 Spec No): 19-21
Lemieux, G. 1974: Trimethoprim-sulfamethoxazole compared with sulfamethoxazole in urinary tract infection Canadian Medical Association Journal 110(8): 910-912
Männistö, P.T. 1976: Comparison of oxolinic acid, trimethoprim, and trimethoprim-sulfamethoxazole in the treatment and long-term control of urinary tract infection Current Therapeutic Research 20(5): 645-654
DuPont, H.L.; Galindo, E.; Evans, D.G.; Cabada, F.J.; Sullivan, P.; Evans, D.J. 1983: Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone Gastroenterology 84(1): 75-80
Stähelin, H.B. 1971: Metabolism and mechanism of action of folic acid Schweizerische Medizinische Wochenschrift 101(7): 243-248
Wesch, G.; Petermann, C.; Linder, M.M. 1983: Drug therapy of peritonitis. 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin Fortschritte der Medizin 101(12): 545-550
Wilson, V.L.; Jones, P.A.; Momparler, R.L. 1983: Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action Cancer Research 43(8): 3493-3496
Springer, C.; Eyal, F.; Michel, J. 1981: Cotrimoxazole (trimethoprim sulfamethoxazole) Harefuah 101(3-4): 80-84
Wormser, G.P. 1978: Trimethoprim-sulfamethoxazole. II. Clinical studies New York State Journal of Medicine 78(13): 2058-2067
Flynn, S.P. 1986: Acute bronchitis and trimethoprim-sulfamethoxazole Journal of Family Practice 23(5): 428
Bergan, T. 1972: Clinical evaluation of sulfamethoxazole-trimethoprim Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(4): 265-269
Liu, L.X.; Seward, S.J.; Crumpacker, C.S. 1986: Intravenous trimethoprim-sulfamethoxazole and ataxia Annals of Internal Medicine 104(3): 448
Whitehead, E. 1975: Use of high-dosage trimethoprim-sulfamethoxazole in sinusitis Canadian Medical Association Journal 112(13 Spec No): 89-90
Markman, M.; Mannisi, J.; Dick, J.D.; Filburn, B.; Santos, G.W.; Saral, R. 1982: Sulfamethoxazole-trimethoprim-resistant pneumococcal sepsis JAMA 248(22): 3011-3012
Glavicki, S. 1971: Clinical experiences with trimethoprim-sulfamethoxazole in pyelonephritis Medizinische Monatsschrift 25(6): 285-287
Huszárné, A.M.; Kálmán, J.; Kerkay, E.; Küttel, D. 1980: Technology and pharmacokinetics of sulfamethoxazole-trimethoprim suppositories Acta Pharmaceutica Hungarica 50(6): 263-269
Da Silva, O.P.; Lobato, E.T. 1971: Use of the sulfamethoxazole-trimethoprim combination in human salmonellosis Revista Brasileira de Medicina 28(7): 373-374
Georgarakis, M. 1980: Densitometric determination of trimethoprim and sulfamethoxazole in tablets Die Pharmazie 35(12): 804
Clementi, K.J. 1975: Treatment of salmonella carriers with trimethoprim-sulfamethoxazole Canadian Medical Association Journal 112(13 Spec No): 28-32